About 1% to 5% of people in the United States have misbehaving antibodies (proteins) in their blood that can lead to APS. Normal antibodies fight infections, but with this condition, things called “autoantibodies” attack certain fats that help with blood clotting. And so your blood starts to clot abnormally.
APS antibodies can sometimes cause:
Blood clots, which can lead to heart attack, stroke, or pulmonary embolism
Miscarriages and other pregnancy complications
Low platelet levels in your blood
Rashes and skin ulcers
(about half of people with lupus also have APS)
My APS
I've tested positive for anti-phospholipid antibodies 4 times (which equates to 100% of the times I was blood tested specifically for those antibodies).
Per my physician I've met all the criteria except full blown stroke, observed clot, or deep vein thrombosis (DVT). Given my Transient Ischemic Attack (TIA or mini stroke) history, my physician was confident in the "hypothesis diagnosis" that I have APS.
And given the final “criteria” to meet a true diagnosis can be catastrophic and fatal (stroke, clot, or DVT), I’m good with only the hypothesis!
As for treatment, my standard Lupus regimen of medications contains 2 medications that also address the APS and aid in blood thinning.
Catastrophic Anti-Phospholipid Syndrome (CAPS)
The most severe and rare form of Anti-Phospholipid Antibody Syndrome is Catastrophic Anti-Phospholipid Syndrome (CAPS).
Per the National Organization of Rare Disorders (NORD) website, CAPS is also referred to as…
Catastrophic antiphospholipid antibody syndrome
Thrombotic storm
…and defined as…
In CAPS multiple blood clots form throughout the body over a short period of time (usually within a week). CAPS is a medical emergency, as clots can cause life-threatening multi-organ failure. The cause of CAPS is unknown. A widely accepted explanation is that it is caused by a combination of gene mutations (making one more susceptible to CAPS) and an environmental trigger, such as an infection, trauma, or surgery.
Get updates delivered to you daily. Free and customizable.
Welcome to NewsBreak, an open platform where diverse perspectives converge. Most of our content comes from established publications and journalists, as well as from our extensive network of tens of thousands of creators who contribute to our platform. We empower individuals to share insightful viewpoints through short posts and comments. It’s essential to note our commitment to transparency: our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. We strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation. Join us in shaping the news narrative together.
Comments / 0